BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33686704)

  • 1. Serologic characteristics of oxaliplatin antibodies in 15 patients with drug-induced immune hemolytic anemia.
    Nguyen TN; Maenulein E; Fihman V; Vinatier I; Moh Klaren J
    Transfusion; 2021 May; 61(5):1609-1616. PubMed ID: 33686704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption.
    Arndt P; Garratty G; Isaak E; Bolger M; Lu Q
    Transfusion; 2009 Apr; 49(4):711-8. PubMed ID: 19192254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune hemolytic anemia with drug-induced antibodies to carboplatin and vincristine in a pediatric patient with an optic pathway glioma.
    Betensky M; Witmer C; Fisher MJ; Nance S; Weiss MJ; Sesok-Pizzini DA
    Transfusion; 2014 Nov; 54(11):2901-5. PubMed ID: 24860959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 1999; 39(11-12):1239-46. PubMed ID: 10604252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: First case of pemetrexed plus cisplatin-induced immune hemolytic anemia in a patient with lung adenocarcinoma.
    Lu H; Wang N; Wang P; Zhang H; Zhao R; Liu H; He X; Liu Z; Chang Y; Cao Y; Wang S
    Front Med (Lausanne); 2022; 9():917485. PubMed ID: 36091696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
    Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
    Front Immunol; 2021; 12():698541. PubMed ID: 35003054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced immune hemolytic anemia.
    Garratty G
    Hematology Am Soc Hematol Educ Program; 2009; ():73-9. PubMed ID: 20008184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic findings in autoimmune hemolytic anemia associated with immunoglobulin M warm autoantibodies.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 2009 Feb; 49(2):235-42. PubMed ID: 18980619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immediate hemolytic reaction induced by repeated administration of oxaliplatin.
    Chen VM; Thrift KM; Morel-Kopp MC; Jackson D; Ward CM; Flower RL
    Transfusion; 2004 Jun; 44(6):838-43. PubMed ID: 15157248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced immune hemolytic anemia associated with anti-carboplatin and the first example of anti-paclitaxel.
    Leger RM; Jain S; Nester TA; Kaplan H
    Transfusion; 2015 Dec; 55(12):2949-54. PubMed ID: 26264449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin-Induced Evans Syndrome: A Possible Dual Mechanism.
    Rousseau C; Nguyen TN; Rebibou JM; Bastie JN; Audia S; Darut-Jouve A; Legendre M
    Clin Colorectal Cancer; 2020 Mar; 19(1):57-60. PubMed ID: 31883972
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-induced immune hemolytic anemia: the last 30 years of changes.
    Arndt PA
    Immunohematology; 2014; 30(2):44-54. PubMed ID: 25247622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of DATs using traditional tube agglutination to gel column and affinity column procedures.
    Dittmar K; Procter JL; Cipolone K; Njoroge JM; Miller J; Stroncek DF
    Transfusion; 2001 Oct; 41(10):1258-62. PubMed ID: 11606825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune hemolytic anemia caused by drugs.
    Garratty G
    Expert Opin Drug Saf; 2012 Jul; 11(4):635-42. PubMed ID: 22502777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first example of a patient with etoricoxib-induced immune hemolytic anemia.
    Mayer B; Genth R; Dehner R; Salama A
    Transfusion; 2013 May; 53(5):1033-6. PubMed ID: 22882551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How we investigate drug-induced immune hemolytic anemia.
    Leger RM; Arndt PA; Garratty G
    Immunohematology; 2014; 30(2):85-94. PubMed ID: 25247618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced immune hemolytic anemia investigation: Comparison between tube test and microcolumn agglutination (gel test) for the detection of drug-dependent antibodies in the presence of soluble drug.
    Nguyen TN; Fihman V; Maenulein E; Vinatier I; Klaren JM
    Transfus Clin Biol; 2020 Aug; 27(3):133-138. PubMed ID: 32561329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first case of drug-induced immune hemolytic anemia due to hydrocortisone.
    Martinengo M; Ardenghi DF; Tripodi G; Reali G
    Transfusion; 2008 Sep; 48(9):1925-9. PubMed ID: 18565121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia--a new paradigm.
    Johnson ST; Fueger JT; Gottschall JL
    Transfusion; 2007 Apr; 47(4):697-702. PubMed ID: 17381629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.